The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global RNAi Technologies Market Research Report 2024
Synopsis
RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics.
The global RNAi Technologies market was valued at US$ 301.3 million in 2023 and is anticipated to reach US$ 430.3 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
North American market for RNAi Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for RNAi Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for RNAi Technologies in Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of RNAi Technologies include Alnylam Pharmaceuticals, Benitec Biopharma Ltd, Filmtec Corporation, Ionis Pharmaceuticals, Quark Pharmaceuticals Inc., RXI Pharmaceuticals, Qiagen, Invitrogen and Ambion, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for RNAi Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNAi Technologies.
Report Scope
The RNAi Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNAi Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNAi Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alnylam Pharmaceuticals
Benitec Biopharma Ltd
Filmtec Corporation
Ionis Pharmaceuticals
Quark Pharmaceuticals Inc.
RXI Pharmaceuticals
Qiagen
Invitrogen
Ambion
Segment by Type
Oncology
Ocular Disorders
Respiratory Disorders
Liver Diseases
Other
Segment by Application
Research
Therapeutics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNAi Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics.
The global RNAi Technologies market was valued at US$ 301.3 million in 2023 and is anticipated to reach US$ 430.3 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
North American market for RNAi Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for RNAi Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for RNAi Technologies in Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of RNAi Technologies include Alnylam Pharmaceuticals, Benitec Biopharma Ltd, Filmtec Corporation, Ionis Pharmaceuticals, Quark Pharmaceuticals Inc., RXI Pharmaceuticals, Qiagen, Invitrogen and Ambion, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for RNAi Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNAi Technologies.
Report Scope
The RNAi Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNAi Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNAi Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alnylam Pharmaceuticals
Benitec Biopharma Ltd
Filmtec Corporation
Ionis Pharmaceuticals
Quark Pharmaceuticals Inc.
RXI Pharmaceuticals
Qiagen
Invitrogen
Ambion
Segment by Type
Oncology
Ocular Disorders
Respiratory Disorders
Liver Diseases
Other
Segment by Application
Research
Therapeutics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNAi Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNAi Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oncology
1.2.3 Ocular Disorders
1.2.4 Respiratory Disorders
1.2.5 Liver Diseases
1.2.6 Other
1.3 Market by Application
1.3.1 Global RNAi Technologies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research
1.3.3 Therapeutics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNAi Technologies Market Perspective (2019-2030)
2.2 RNAi Technologies Growth Trends by Region
2.2.1 Global RNAi Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 RNAi Technologies Historic Market Size by Region (2019-2024)
2.2.3 RNAi Technologies Forecasted Market Size by Region (2025-2030)
2.3 RNAi Technologies Market Dynamics
2.3.1 RNAi Technologies Industry Trends
2.3.2 RNAi Technologies Market Drivers
2.3.3 RNAi Technologies Market Challenges
2.3.4 RNAi Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNAi Technologies Players by Revenue
3.1.1 Global Top RNAi Technologies Players by Revenue (2019-2024)
3.1.2 Global RNAi Technologies Revenue Market Share by Players (2019-2024)
3.2 Global RNAi Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNAi Technologies Revenue
3.4 Global RNAi Technologies Market Concentration Ratio
3.4.1 Global RNAi Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNAi Technologies Revenue in 2023
3.5 RNAi Technologies Key Players Head office and Area Served
3.6 Key Players RNAi Technologies Product Solution and Service
3.7 Date of Enter into RNAi Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNAi Technologies Breakdown Data by Type
4.1 Global RNAi Technologies Historic Market Size by Type (2019-2024)
4.2 Global RNAi Technologies Forecasted Market Size by Type (2025-2030)
5 RNAi Technologies Breakdown Data by Application
5.1 Global RNAi Technologies Historic Market Size by Application (2019-2024)
5.2 Global RNAi Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America RNAi Technologies Market Size (2019-2030)
6.2 North America RNAi Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America RNAi Technologies Market Size by Country (2019-2024)
6.4 North America RNAi Technologies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNAi Technologies Market Size (2019-2030)
7.2 Europe RNAi Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe RNAi Technologies Market Size by Country (2019-2024)
7.4 Europe RNAi Technologies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNAi Technologies Market Size (2019-2030)
8.2 Asia-Pacific RNAi Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific RNAi Technologies Market Size by Region (2019-2024)
8.4 Asia-Pacific RNAi Technologies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNAi Technologies Market Size (2019-2030)
9.2 Latin America RNAi Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America RNAi Technologies Market Size by Country (2019-2024)
9.4 Latin America RNAi Technologies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNAi Technologies Market Size (2019-2030)
10.2 Middle East & Africa RNAi Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa RNAi Technologies Market Size by Country (2019-2024)
10.4 Middle East & Africa RNAi Technologies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Detail
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals RNAi Technologies Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in RNAi Technologies Business (2019-2024)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Benitec Biopharma Ltd
11.2.1 Benitec Biopharma Ltd Company Detail
11.2.2 Benitec Biopharma Ltd Business Overview
11.2.3 Benitec Biopharma Ltd RNAi Technologies Introduction
11.2.4 Benitec Biopharma Ltd Revenue in RNAi Technologies Business (2019-2024)
11.2.5 Benitec Biopharma Ltd Recent Development
11.3 Filmtec Corporation
11.3.1 Filmtec Corporation Company Detail
11.3.2 Filmtec Corporation Business Overview
11.3.3 Filmtec Corporation RNAi Technologies Introduction
11.3.4 Filmtec Corporation Revenue in RNAi Technologies Business (2019-2024)
11.3.5 Filmtec Corporation Recent Development
11.4 Ionis Pharmaceuticals
11.4.1 Ionis Pharmaceuticals Company Detail
11.4.2 Ionis Pharmaceuticals Business Overview
11.4.3 Ionis Pharmaceuticals RNAi Technologies Introduction
11.4.4 Ionis Pharmaceuticals Revenue in RNAi Technologies Business (2019-2024)
11.4.5 Ionis Pharmaceuticals Recent Development
11.5 Quark Pharmaceuticals Inc.
11.5.1 Quark Pharmaceuticals Inc. Company Detail
11.5.2 Quark Pharmaceuticals Inc. Business Overview
11.5.3 Quark Pharmaceuticals Inc. RNAi Technologies Introduction
11.5.4 Quark Pharmaceuticals Inc. Revenue in RNAi Technologies Business (2019-2024)
11.5.5 Quark Pharmaceuticals Inc. Recent Development
11.6 RXI Pharmaceuticals
11.6.1 RXI Pharmaceuticals Company Detail
11.6.2 RXI Pharmaceuticals Business Overview
11.6.3 RXI Pharmaceuticals RNAi Technologies Introduction
11.6.4 RXI Pharmaceuticals Revenue in RNAi Technologies Business (2019-2024)
11.6.5 RXI Pharmaceuticals Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Detail
11.7.2 Qiagen Business Overview
11.7.3 Qiagen RNAi Technologies Introduction
11.7.4 Qiagen Revenue in RNAi Technologies Business (2019-2024)
11.7.5 Qiagen Recent Development
11.8 Invitrogen
11.8.1 Invitrogen Company Detail
11.8.2 Invitrogen Business Overview
11.8.3 Invitrogen RNAi Technologies Introduction
11.8.4 Invitrogen Revenue in RNAi Technologies Business (2019-2024)
11.8.5 Invitrogen Recent Development
11.9 Ambion
11.9.1 Ambion Company Detail
11.9.2 Ambion Business Overview
11.9.3 Ambion RNAi Technologies Introduction
11.9.4 Ambion Revenue in RNAi Technologies Business (2019-2024)
11.9.5 Ambion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
